ABSTRACT
Objetivo. Determinar la disposición de los padres de hijas adolescentes a pagar por una vacuna contra el virus del papiloma humano en la Región del Maule, Chile. Material y métodos. Se utilizó una muestra de 386 padres con hijas entre 12 y 18 años, representativa de las cinco ciudades de mayor población de la Región del Maule, estratificada socioeconómicamente. La disposición a pagar se obtuvo usando el método de valoración contingente en su formato dicotómico doble. Resultados. Los padres están dispuestos a pagar en promedio 126.538 pesos chilenos para vacunar a sus hijas contra el virus; el precio y número de hijas afecta negativamente la probabilidad de la disposición a pagar, y el ingreso familiar afecta positivamente dicha probabilidad. Conclusión. Existe la posibilidad de utilizar financiamiento compartido entre el Estado y los padres de las potenciales hijas que puedan recibir la vacuna contra el virus del papiloma humano para reducir la incidencia de cáncer de cuello uterino.
Objective. To determine the willingness to pay of parents of teenage daughters for a vaccine against human papillomavirus in the Maule Region, Chile. Materials and methods. A sample of 386 parents with daughters between 12 and 18 years old, representing the five largest cities of the Region of Maule, socioeconomically stratified. WTP was obtained using the contingent valuation method in double bounded format. Results. Parents are willing to pay an average of US$ 252.71 to vaccinate their daughters against virus, where the price and number of daughters negatively affects the probability of willingness to pay, and family income positively affects the probability. Conclusion. There is a possibility of using shared funding between the government and the parents of potential daughter to be affected by the human papillomavirus to reduce cervical cancer events.
Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Attitude to Health , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/economics , Parents/psychology , Uterine Cervical Neoplasms/prevention & control , Chile , Costs and Cost AnalysisABSTRACT
Background: Human papillomavirus (HPV) infection is a risk factor for cervical cancer and can be prevented with the HPV vaccine. Aim: To explore the willingness of parents to pay for HPV vaccine for their offspring. Material and Methods: A survey about the willingness to pay for HPV vaccine was answered by 386 individuals of the highest socioeconomic level who had a daughter aged between 12 and 18 years. The survey included information about the risks of HPV infection. Results: Parents would pay a mean of US$ 758 for the vaccine. Twenty five percent of parents were not willing to pay for it. If the cost of the vaccine would be reduced by 50%, only 4% of parents would not pay for it. The willingness to pay is associated with the price of the vaccine, the income level of respondents and the size of the family. Conclusions: Most respondents would pay for HPV vaccine for their daughters, despite the relatively high cost.
Subject(s)
Adolescent , Child , Female , Humans , Financing, Personal/statistics & numerical data , Papillomavirus Infections/economics , Papillomavirus Vaccines/economics , Chile , Choice Behavior , Family Characteristics , Financing, Personal/economics , Models, Economic , Papillomavirus Infections/prevention & control , Surveys and Questionnaires , Socioeconomic Factors , Urban PopulationABSTRACT
Background: Environmental air pollution is associated with a higher incidence of respiratory diseases, absenteeism and costs. Aim: To model the health related economic benefits associated to a reduction in air pollution and the resulting lower prevalence of respiratory diseases, in a Chilean city. Material and Methods: A time series model for year 2006 was elaborated. The dependent variable was the number of consultations for respiratory disease. The independent variables were air pollution expressed as particulate matter of 10 micrometers or less (PM10), minimum and maximum environmental temperatures, environmental humidity and number of consultations for chronic diseases. Results: The variables that best explained the number of consultations for respiratory diseases were PM10, minimal environmental temperatures and preexisting respiratory diseases. In a hypothetical scenery of a 67 percent reduction in PM10, 69 percent of medical consultations for respiratory diseases would be avoided. This would result in a net saving of US$ 345,000 per year. Conclusions: The reduction in PM10 emissions would result in an important reduction in consultations for respiratory diseases and monetary savings.